Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies
Main Article Content
Keywords
psoriasis, tildrakizumab, clinical trial
Abstract
Abstract not available.
Study supported by Merck & Co., Inc.